logo-loader
viewClinigen Group PLC

Clinigen Group reports on 'transformational' year with strong profit growth

Clinigen Group PLC's (LON:CLIN) head of investor relations Matt Parrish caught up with Proactive London's Andrew Scott following the release of the firm's results for the year to June 2019.

The firm's gross profit was up 30% at £182.3mln, while revenues were ahead 20% at £456.9mln. Underlying earnings (EBITDA) jumped up 33% at £100.8mln.

Parrish adds that their latest acquisition, CMS, is performing ahead of expectations.

Quick facts: Clinigen Group PLC

Price: 793 GBX

AIM:CLIN
Market: AIM
Market Cap: £10.55 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Clinigen Group PLC named herein, including the promotion by the Company of Clinigen Group PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Jersey Oil & Gas awarded Greater Buchan acreage

Headlines from the Proactive UK newsroom. Jersey Oil and Gas PLC (LON:JOG) has confirmed it has landed new acreage from the UK government’s 31st Supplementary Offshore Licensing Round. The North Sea explorer told investors that following the completion of paperwork it has now been formally...

on 19/9/19

2 min read